...
首页> 外文期刊>World Journal of Gastroenterology >Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression
【24h】

Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression

机译:幽门螺杆菌通过增强乙酰肝素酶表达促进胃癌的侵袭和转移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AIM To detect the mechanisms of Helicobacter pylori ( H. pylori ) infection in the invasion and metastasis of gastric cancer (GC). METHODS Specimens from 99 patients with GC were collected. The correlation among H. pylori infection, heparanase (HPA) and mitogen-activated protein kinase (MAPK) expression, which was determined by immunohistochemistry, and the clinical features of GC was analysed using SPSS 22.0. Overall survival (OS) and relapse-free survival (RFS) of GC patients were estimated by the Kaplan-Meier method. Independent and multiple factors of HPA and MAPK with prognosis were determined with COX proportional hazards models. HPA and MAPK expression in MKN-45 cells infected with H. pylori was analysed using Western blot. RESULTS H. pylori infection was observed in 70 of 99 patients with GC (70.7%), which was significantly higher than that in healthy controls. H. pylori infection was related to lymph metastasis and expression of HPA and MAPK ( P 0.05); HPA expression was relevant to MAPK expression ( P = 0.024). HPA and MAPK expression in MKN-45 cells was significantly upregulated following H. pylori infection and peaked at 24 h and 60 min, before decreasing ( P 0.05). SB203580, an inhibitor of MAPK, significantly decreased HPA expression. HPA was related to lymph metastasis and invasive depth. HPA positive GC cases and H. pylori positive GC cases showed poorer prognosis than HPA negative cases ( P 0.05). COX models showed that the prognosis of GC was connected with HPA expression, lymph metastasis, tissue differentiation, and invasive depth. CONCLUSION H. pylori may promote the invasion and metastasis of GC by increasing HPA expression that may associate with MAPK activation, thus causing a poorer prognosis of GC.
机译:目的探讨幽门螺杆菌(H. pylori)感染在胃癌(GC)侵袭和转移中的作用机制。方法收集99例胃癌患者的标本。幽门螺杆菌感染,乙酰肝素酶(HPA)和有丝分裂原活化蛋白激酶(MAPK)表达之间的相关性,通过免疫组织化学确定,并使用SPSS 22.0分析GC的临床特征。通过Kaplan-Meier方法评估了GC患者的总生存期(OS)和无复发生存期(RFS)。使用COX比例风险模型确定HPA和MAPK与预后的独立因素和多重因素。使用蛋白质印迹分析幽门螺杆菌感染的MKN-45细胞中的HPA和MAPK表达。结果99例胃癌患者中有70例发生了幽门螺杆菌感染(70.7%),明显高于健康人。幽门螺杆菌感染与淋巴结转移及HPA和MAPK的表达有关(P <0.05); HPA表达与MAPK表达相关(P = 0.024)。幽门螺杆菌感染后,MKN-45细胞中的HPA和MAPK表达显着上调,并在降低前于24 h和60 min达到峰值(P <0.05)。 MAPK抑制剂SB203580可显着降低HPA表达。 HPA与淋巴转移和浸润深度有关。 HPA阳性GC病例和幽门螺杆菌阳性GC病例的预后较HPA阴性病例差(P <0.05)。 COX模型显示,GC的预后与HPA表达,淋巴转移,组织分化和浸润深度有关。结论幽门螺杆菌可能通过增加可能与MAPK激活相关的HPA表达来促进GC的侵袭和转移,从而导致GC的预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号